
Marta C. Figueiredo
Contributor at Freelance
Assistant Professor at Eindhoven University of Technology, electrochemistry, catalysis, energy, sustainability, carbon dioxide utilization
Articles
-
2 months ago |
porphyrianews.com | Marisa Wexler |Kalyn N Shelton |Steve Bryson |Marta C. Figueiredo
People with acute intermittent porphyria (AIP) often consume large amounts of simple sugars and fats, which may contribute to metabolic problems, such as being overweight or having high levels of bad cholesterol in their blood, a study reports. “Our study provided valuable insights into the metabolic aspects of AIP, revealing improper dietary habits that may predispose patients to additional pathologies [health problems],” the researchers wrote.
-
2 months ago |
smanewstoday.com | Steve Bryson |Katherine Poinsatte |Marta C. Figueiredo |Sherry Toh
Three men with late-onset spinal muscular atrophy (SMA) undergoing treatment with the approved therapy Evrysdi (risdiplam) were able to conceive with their partners, a case series reported. None of the pregnancies were planned, and the researchers noted there were no missed treatment doses. Among the three, one pregnancy was voluntarily terminated, while the other two men’s partners gave birth to healthy babies.
-
2 months ago |
alsnewstoday.com | Lila Levinson |Lindsey Shapiro |Patricia Inacio |Marta C. Figueiredo
Daily treatment with IPL344 for up to three years was safe and appeared to slow amyotrophic lateral sclerosis (ALS) progression, according to recently published data from a small Phase 2a clinical trial. Patients undergoing treatment gained weight and experienced slower declines in functional abilities and lung function. The treatment also lengthened survival in patients, compared with external placebo groups.
-
2 months ago |
huntingtonsdiseasenews.com | Marisa Wexler |Becky Field |Margarida Maia |Marta C. Figueiredo
Mental health problems are common in Huntington’s disease, but there isn’t much data on patients’ use of psychiatric medications, a review study reports. “Although [neuropsychiatric problems] in [Huntington’s disease] are common, hardly any clinical trials have addressed their treatment,” the study’s researchers wrote.
-
Mar 17, 2025 |
cysticfibrosisnewstoday.com | Jennifer Bleecher |Margarida Maia |Marta C. Figueiredo |Shelby Dell
In the first few days after my double-lung transplant in 2020, I was looking at a hand-held mirror and saw a central venous catheter protruding from the left side of my neck. A large, bulky bandage covered the right side. Little did I know then that the bandage represented something that would change my health and long-term treatment. My right arm and hand were also grossly swollen.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 299
- DMs Open
- No